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Our previous study (31) has shown that IL-1␤ increases intracellular ceramide production in 5 min and that C 2 -ceramide mediates the IL-1␤-induced decrease in L-type Ca 2ϩ channel current (I Ca,L ) in adult rat ventricular myocytes. Other studies in rat ventricular myocytes have also shown that C 2 -ceramide reduces I Ca,L (29) , whereas sphingosine, an interconvertible metabolite of ceramide, completely abolishes Ca 2ϩ transients (29) and inhibits I Ca,L (29, 38) . Sphingosine has also been shown to inhibit Ca 2ϩ -induced Ca 2ϩ release (CICR) from the sarcoplasmic reticulum (SR) (10, 35) . In contrast, studies in smooth muscle cells and Swiss 3T3 fibroblasts have shown that sphingosine increases intracellular Ca 2ϩ (Ca i 2ϩ ) by enhancing Ca 2ϩ release from intracellular stores (33) . It is unclear whether sphingosine has different effects on different Ca i 2ϩ stores; little is also known about how ceramide affects Ca i 2ϩ homeostasis and contractile function in the heart. Thus, in this study, we investigated the effects of ceramide on contractile function and excitation-contraction (E-C) coupling of adult ventricular myocytes and on left ventricular (LV) function of isolated adult rat hearts. We found that ceramide exerted positive inotropic and lusitropic effects despite reductions in I Ca,L .
MATERIALS AND METHODS
Myocyte isolation. Single ventricular myocytes were isolated from hearts of adult (3-6 mo old) male Sprague-Dawley rats using enzymatic dissociation as described previously (25) . Isolated myocytes were harvested and plated onto culture dishes containing culture medium. Rod-shaped cells with clear striations were used for experiments, and all experiments were carried out at 35-37°C. The protocol for the use of animals in this study conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee.
Electrophysiological measurements. Ventricular myocytes were placed on the heated stage of an inverted microscope (Nikon Diaphot) and perfused with normal Tyrode solution containing (in mM) 140 NaCl, 5.4 KCl, 1 CaCl 2, 0.8 MgCl2, 10 HEPES-Tris, and 5.6 glucose (pH 7.40 at 37°C, 290 mosM). Myocytes were patch clamped using conventional whole cell patch techniques (14) with a patch-clamp amplifier (Axopatch 200A, Axon Instruments) (25) . The simultaneous measurement of whole cell ICa,L and cell shortening (CS) was measured in K ϩ -rich pipette solutions containing (in mM) 120 K-aspartate, 25 KCl, 2 MgCl2, 5 Na2ATP, 0.4 Li4GTP, 10 HEPES-Tris, and 5.6 glucose (pH 7.10 at 37°C) using the conventional whole cell patch-clamp techniques as described previously (25) .
Measurement of CS. Unloaded CS or contraction of myocytes was elicited in normal Tyrode solution and measured as described previously (26) . Briefly, cells were then superfused with Tyrode solution containing appropriate concentrations of DMSO for 5-7 min and subsequently with Tyrode solution containing different concentrations of C2-ceramide for 3-10 min before being switched back to the DMSO control. CS was monitored with a video edge-motion detector system (Crescent Electronics; Sandy, UT). The measured parameters of contractile function in single myocytes included the peak magnitude of CS, maximum rates of contraction (ϩdL/dtmax) and relaxation (ϪdL/dtmax), and the duration of CS.
Measurement of intracellular free Ca 2ϩ concentration. Intracellular free Ca 2ϩ concentration in ventricular myocytes was measured as described previously (26) . Briefly, ventricular myocytes seeded on 25-mm coverslips in culture medium were loaded with 2 M fura-PE3-AM for 30 min in a culture incubator at 37°C. Myocytes were then transferred to a perfusion chamber on the stage of an inverted microscope (Nikon TE300; Irving, TX) and superfused with normal Tyrode solution. After subtraction of the background signal, fluorescent signals were recorded as the intensity ratio (R or F340/F380), i.e., the fluorescent intensity when fura-PE3 was excited at 340 nm (F340) divided by that when excited at 380 nm (F380). The measured parameters of the Ca 2ϩ transient included peak magnitude, maximum rates of the rising phase (ϩdR/dtmax) and the declining phase (ϪdR/dtmax), and rise and decay times between 10% and 90% of the peak amplitude. In some experiments, contraction of ventricular myocytes was recorded simultaneously with Ca 2ϩ transients. Langendorff-perfused hearts. Hearts were isolated from adult male Sprague-Dawley rats (300-350 g) and perfused via the aorta with an oxygenated Krebs-Henseleit solution (37°C) of the following composition (in mM): 118.0 NaCl, 27.1 NaHCO3, 3.7 KCl, 1.8 CaCl2, 1.2 MgCl2, 1.0 KH2PO4, and 11.1 glucose (pH 7.4 was maintained by saturation with 95% O2-5% CO2 gas). Hearts were perfused at a constant flow rate of 7.0 ml ⅐ g heart Ϫ1 ⅐ min Ϫ1 , similar to that observed when flow is examined at a constant pressure of 80 mmHg. Coronary perfusion pressure was monitored continuously throughout the experiment with a Statham pressure transducer. Both atria were removed, and the ventricles were paced electrically at 250 beats/min by platinum contact electrodes positioned on the interventricular septum. A fluidfilled latex balloon catheter was placed in the LV to measure intraventricular pressure. Steady-state contractile function was monitored throughout experiments and recorded 10-15 min after in control, DMSO-containing solutions and subsequent perfusion with ceramide-containing buffer solutions. Measured parameters of LV function included peak systolic and diastolic pressures, maximum rates of pressure development (ϩdP/dtmax) and relaxation (ϪdP/dtmax), and developed pressure (LVDP) at various preload balloon volumes (10-90 l, a range that elicited maximum contractility in all preparations). In addition to a polygraph recording, all data were acquired and analyzed with a software program (CODAS, DataQ Instruments; Akron, OH).
Chemicals. Most reagents were purchased from Sigma Chemical (St. Louis, MO) and directly added when needed. Ceramides were purchased from Matreya (Present Gap, PA). Stock solutions of ceramide (10 Ϫ2 M) were prepared in DMSO; the final concentration in solutions was Յ0.1%.
Statistics. In all experiments, data in response to ceramide were compared with the steady-state control before the treatment in each individual cells and thus expressed as a ratio or percentage of each control value before being combined for statistical analysis. Values are presented as means Ϯ SE. Statistical significance (P Ͻ 0.05) was evaluated by the twotailed Student's paired t-test, or, when more than two conditions were compared, by one-or two-way ANOVA with Duncan's multiple-range test.
RESULTS

Effects of ceramide on contraction in patch-clamped adult ventricular myocytes.
We (31) have previously shown that C 2 -ceramide decreases I Ca,L concentration dependently in adult rat ventricular myocytes. This ceramide-induced decrease in I Ca,L led to the hypothesis that ceramide elicits a negative inotropy. Thus we examined the inotropic effect of ceramide by monitoring contraction simultaneously with I Ca,L in patchclamped myocytes. Figure 1 , A and B, shows a typical voltage dependency of I Ca,L and contraction (or CS) in the same cell, respectively, in the absence and presence of a natural-form ceramide (n-ceramide). Results show that the voltage dependency of CS in control (before exposure to ceramide) was almost identical to that of simultaneously recorded I Ca,L . Figure 1A also shows that exposure for 8 min to 10 M n-ceramide reduced I Ca,L , consistent with our previous findings with C 2 -ceramide (31). However, to our surprise, Fig. 1B shows that in the presence of ceramide, the amplitude of CS, which was associated with voltage-dependent activation of I Ca,L , was increased concurrently with an increase in the duration (see Fig. 1B , inset, measured at 0 mV). The combined data showed that, whereas nceramide reduced the amplitude of I Ca,L to 70 Ϯ 8% (n ϭ 10, measured at 0 mV) of control, it increased contraction by 56 Ϯ 21% in five of six cells. These results suggest that ceramide alters Ca i 2ϩ handling and/or Ca 2ϩ sensitivity of the contractile apparatus.
Effects of ceramide on contraction of intact adult ventricular myocytes.
Because ventricular myocytes became very arrhythmogenic during exposure to ceramide under patch-clamped conditions, we examined the inotropic effect of ceramide in intact ventricular myocytes under more physiological conditions. Figure  2A shows that exposure to 3 M C 2 -ceramide caused an initial, small, transient decrease in contraction, followed by an increase in systolic and diastolic levels, and reached a steady state in 10 min. Figure 2B shows that C 2 -ceramide elicited a positive inotropic effect in a concentration-dependent manner. Data also show that n-ceramide had a similar positive inotropic effect (increasing by 47%) to C 2 -ceramide. In contrast, C 8 -ceramide and dihydro-C 2 -ceramide, a biologically inactive analog of C 2 -ceramide, had little effect on CS (1.04 Ϯ 0.03%, n ϭ 3, and 1.05 Ϯ 0.08%, n ϭ 4, vs. control, respectively).
The kinetic parameters of contraction were then analyzed in the presence of C 2 -ceramide. For example, in the results shown in Fig. 2A , after the diastolic level was offset to 0, steady-state CS traces (averaged from 5 to 6 traces) before and during exposure to C 2 -ceramide were superimposed and are shown in Fig. 3A . The first derivatives of each CS trace are shown in Fig. 3A , inset, to obtain ϩdL/dt max and ϪdL/dt max . C 2 -ceramide increased ϩdL/dt max and ϪdL/dt max by 34% and 20%, respectively, and lengthened the time to peak ϳ17% and the duration of CS. The data summarized in Fig.  3B show that C 2 -ceramide enhanced ϩdL/dt max , ϪdL/ dt max , and the duration of CS (or the area under the CS trace) concomitant with a reduction in the decay time in a concentration-dependent manner. These results suggest that C 2 -ceramide elicited positive inotropic and lusitropic effects in adult rat ventricular myocytes.
The inotropic effect of ceramide could involve the enhancement of SR function and of the kinetics and/or Ca 2ϩ sensitivity of contractile proteins. Postrest potentiation (PRP) protocols have been used as an indirect indicator for Ca i 2ϩ handling by the SR (7) and the Ca 2ϩ response of contractile proteins. After a short period of cessation of electrical stimulation (rest interval), rat ventricular myocytes display a PRP of contraction followed by a recovery (7). Thus we used this PRP protocol to examine whether ceramide alters Ca i 2ϩ handling. Figure 4A shows that 10 M C 2 -ceramide significantly enhanced the potentiated contraction after a 30-s rest (PRP 30 ); however, the degree of potentiation relative to prerest CS level (i.e., the ratio of the amplitude of PRP 30 to that of prerest steady-state CS) was decreased. The combined data show that compared with the control PRP 30 , C 2 -ceramide increased the amplitude and duration of PRP 30 by ϳ22% and 36%, respectively (Fig. 4B) , and reduced the relative potentiation of PRP 30 by 18 Ϯ 4% (n ϭ 9, P Ͻ 0.005, paired t-test; Fig. 4C ). These data suggest increases in fractional Ca 2ϩ release from the SR and the Ca 2ϩ response of contractile proteins in the presence of ceramide. Moreover, the time course of the recovery of potentiated systolic shortening was best fit by a double-exponential function (Fig. 4B, inset) . The fast time constant (but not the slow time constant) of recovery from PRP 30 was significantly increased in the presence of C 2 -ceramide.
Effects of ceramide on the Ca 2ϩ transient. The effects of ceramide on Ca i 2ϩ handling were examined using fura-PE3-loaded ventricular myocytes. Figure 5A shows that exposure to 1 M C 2 -ceramide significantly increased systolic and diastolic shortening and the magnitude of contraction, consistent with those in nonfura-PE3-loaded cells ( Fig. 2A) before contracture. C 2 -ceramide slightly increased systolic and diastolic free Ca i 2ϩ and the magnitude of the Ca 2ϩ transient (i.e., the difference between systolic and diastolic level) (Fig.  5B) . In contrast to a 80% increase in CS, Fig. 5C shows that ceramide increased the magnitude of the Ca 2ϩ transient only by 9% with an increase in ϩdR/dt max of the Ca 2ϩ transient but with a smaller effect on ϪdR/ dt max at 1 M (Fig. 5C, inset) . Under these conditions, the increased ϪdL/dt max with little change in ϪdR/ dt max could be due to an underestimate of the maximum rate of Ca 2ϩ return (ϪdCa/dt max ) by ϪdR/dt max . Figure 5 , E and F, shows that ceramide-induced changes in the magnitude and kinetics of the Ca 2ϩ transient were concentration dependent. Ceramide (at concentrations Ն3 M) significantly increased ϩdR/ dt max and ϪdR/dt max . The results also showed that n-ceramide had a similar but smaller effect (12.2 Ϯ 2.2%, n ϭ 4) than C 2 -ceramide at 10 M, whereas dihydro-C 2 -ceramide displayed little effect (103.2 Ϯ 1.3% of control, n ϭ 3). The differential effect of ceramide on CS and the Ca 2ϩ transient suggests an increase in the Ca 2ϩ sensitivity of contractile proteins. After a phase-plane plot of CS and simultaneously measured free Ca i 2ϩ (or the fluorescence ratio), Fig. 5D shows that a hysteresis relationship between CS and fluorescence ratio was shifted upward in the presence of C 2 -ceramide. Figure 5D , inset, shows that when this relationship was replotted using relative changes in the CS-vs.-fluorescence ratio (normalized to each peak magnitude), a leftward shift in the contraction-Ca i 2ϩ trajectory was revealed during the early phase of relaxation, suggesting an increase in the myofilament Ca i 2ϩ sensitivity, as described previously by others (34) . Furthermore, the effect of ceramide on the response of CS to extracellular Ca 2ϩ (Ca o 2ϩ ) was examined and is shown in Fig. 6A . In a representative experiment, both the systolic and diastolic states of CS were increased in response to increasing the Ca o 2ϩ concentration ([Ca 2ϩ ] o ) to 2 mM. Figure 6B shows that the Ca o 2ϩ -induced increase in CS was enhanced in the presence of 3 M C 2 -ceramide. Figure 6C shows that the time courses of the Ca o 2ϩ response of CS before, during, and after exposure to C 2 -ceramide were curve fit by a single exponential function. The time constant of the on rate ( on ) in response to 2 mM [Ca 2ϩ ] o was 12.0 and 13.8 s in the absence and presence of C 2 -ceramide, respectively. The time constant of the off rate ( off ) was also increased in the presence of C 2 -ceramide (from 14.2 to 18.9 s). The amplitude of CS and time constants of the Ca 2ϩ response only partially recovered after removal of C 2 -ceramide. The combined data show that C 2 -ceramide (3 M) increased on and off of the Ca o 2ϩ response by 57 Ϯ 18% and 75 Ϯ 23% (n ϭ 10), respectively. These results support the suggestion that ceramide increases the Ca 2ϩ sensitivity of contractile proteins.
We then examined whether ceramide alters the SR Ca 2ϩ load by applying a brief pulse (ϳ5 s) of 10-15 mM caffeine, which has been used to estimate SR Ca content (6, 12) , after a 15-s termination of electrical stimulation. Figure 7A shows an experiment in which a caffeine pulse was applied to the cell before, during, and after exposure to C 2 -ceramide. In addition, a PRP 30 protocol was repetitively performed under the same conditions. Figure 7B shows that in addition to increasing the amplitude and ϩdR/dt max of the Ca 2ϩ transient, 10 M C 2 -ceramide increased ϪdR/dt max (Fig. 7B, inset) . Figure 7A shows that the magnitude of the caffeine-induced Ca 2ϩ transient was slightly reduced in the presence of C 2 -ceramide (also see Fig. 7C ). Upon the removal of C 2 -ceramide, the caffeine-induced Ca 2ϩ transient was transiently increased before returning to the control level. The combined data of the caffeine-induced Ca 2ϩ transient shown in Fig. 7D show that 10 M C 2 -ceramide reduced the magnitude of the caffeine-induced Ca 2ϩ transient by 11%. Consequently, the steady-state fractional SR Ca 2ϩ release (a ratio of steady-state systolic amplitude to caffeine-induced amplitude) was greater in the presence of C 2 -ceramide than in control (67% vs. 56% in control), supporting the results obtained from CS. Figure 7D also shows that the time constant of the decline phase of the caffeineinduced Ca 2ϩ transient was increased by 18% in the presence of C 2 -ceramide, suggesting a reduction in Ca 2ϩ efflux via sarcolemmal Na ϩ /Ca 2ϩ exchange. In addition, upon the removal of caffeine (postcaffeine), the magnitude of the first electrically elicited Ca 2ϩ transient in the presence of C 2 -ceramide was 17 Ϯ 4% (n ϭ 6) smaller than that in control, suggesting a reduced Ca 2ϩ influx, which is consistent with a ceramide-induced reduction in I Ca,L .
Ca i 2ϩ handling by the SR was also examined in fura-PE3-loaded myocytes using the PRP 30 protocol. C 2 -ceramide slightly increased the magnitude of the PRP 30 -elicited Ca 2ϩ transient by 7 Ϯ 3% (n ϭ 6, P ϭ 0.045, one-tailed paired t-test). Similar to the PRP 30 of CS (in Fig. 4C ), Fig. 7E shows that the relative amplitude (to the prerest level) of the PRP 30 -associated Ca 2ϩ transient was significantly smaller in the presence of C 2 -ceramide than in control. These results reinforced that C 2 -ceramide increases the fractional SR Ca 2ϩ release in regular twitches.
Effects of C 2 -ceramide on LV contractile function in isolated hearts. We next examined whether C 2 -ceramide affects LV function in isolated whole heart preparations. In control experiments, isolated hearts were perfused with normal Tyrode solution for 10 min before the addition of 0.1% DMSO for 30-45 min, and the results showed that DMSO produced no significant changes in LV contractile function. Figure 8A shows a representative experiment in which perfusion for 10 min with 10 M C 2 -ceramide enhanced systolic LV pressure accompanied by increases in ϩdP/dt max and ϪdP/dt max at a balloon volume of 50 l. Figure 8B shows combined data from three hearts of C 2 -ceramide-induced increases in LV systolic pressure at balloon volumes of 30-80 l and diastolic pressure only at balloon volumes of 70-80 l. C 2 -ceramide also increased LVDP (i.e., the difference between systolic pressure and diastolic pressure) by ϳ15% (filled circles in Fig. 8D ). The kinetic parameters of LV contractile function were analyzed under these conditions. C 2 -ceramide significantly enhanced ϩdP/dt with a smaller effect on ϪdP/dt (Fig. 8C) . The summarized data shown in Fig. 8D show that C 2 -ceramide increased ϩdP/dt max by 20-25% throughout the tested volumes (filled squares) but increased ϪdP/dt max only at balloon volumes of 30-50 l (filled triangles). Similarly, in three other hearts, 3 M C 2 -ceramide increased LVDP, ϩdP/ dt max , and ϪdP/dt max by 22.8 Ϯ 3.7%, 20.9 Ϯ 1.3%, and 14.2 Ϯ 4.6%, respectively, at a balloon volume of 40 l. These results suggest that C 2 -ceramide exerts a positive inotropic effect on LV myocardium with a maxi- concentration (Cao) from 1 to 2 mM (A). After recovering from 2 mM Ca 2ϩ , the myocyte was exposed for 5 min to 3 M C2-ceramide, followed by another exposure to 2 mM Ca 2ϩ (B). C: time course of changes in CS amplitude (difference between systole and diastole) in response to 2 mM Ca 2ϩ before (E), during (F), and after (‚) exposure to C2-ceramide. The on and off responses to 2 mM Ca 2ϩ were curve fit by a single exponential function to obtain the time constants of the on and off rate (solid lines). mum effect at 3 M. Moreover, it is worth mentioning that 3 and 10 M C 2 -ceramide caused an initial, transient decrease in LVDP by 6.6 Ϯ 1.3 and 7.0 Ϯ 0.9 mmHg, respectively, in the first 2 min during perfusion concomitantly with a small drop in coronary pressure.
DISCUSSION
We (31) have previously reported that ceramide production is increased in response to IL-1␤ stimulation in adult rat ventricular myocytes. C 2 -ceramide has also been shown to reduce I Ca,L in these preparations (29, 31) . The present study demonstrated that despite its reduction in I Ca,L , ceramide induced a positive inotropic effect and an increase in systolic free Ca i 2ϩ , a positive lusitropic effect, and an increase in the Ca 2ϩ sensitivity of contractile proteins. Ceramide also enhanced LV systolic and diastolic function, but with less effect on diastolic function.
In patch-clamped myocytes, n-ceramide, a naturally occurring ceramide, produced an inhibitory effect on I Ca,L , similar to C 2 -ceramide, as described previously (31) . This effect, however, was accompanied by increases in systolic amplitude and the duration of contraction. n-Ceramide also produces a positive inotropic effect in intact myocytes, again similar to that induced by C 2 -ceramide. These results support the notion that C 2 -ceramide mimics the naturally occurring ceramide in altering cardiac electric and mechanical function. The present study also suggests that the ceramideinduced inotropic effect is specific and probably inde- pendent of the length of the N-acyl hydrocarbon chain because dihydro-C 2 -ceramide and C 8 Rest-dependent potentiation of contraction has been suggested to result from a recovery of the E-C coupling from a refractory state with an increased fraction of SR Ca 2ϩ release, relatively independent of SR Ca 2ϩ content (7) . In addition to increased fractional Ca 2ϩ release, ceramide increases the duration and magnitude of PRP 30 -elicited CS without a significant change in the respective Ca 2ϩ transient. While ceramide might facilitate the recovery of refractoriness of E-C coupling, our data strongly suggest that it increases the Ca 2ϩ sensitivity or active state of contractile machinery for the following reasons: 1) the degree of the ceramide-induced increase in CS (e.g., the systole and the duration) is greater than in the Ca 2ϩ transient in regular twitches; 2) the ceramide-induced increase in the diastolic level of CS without a significant change in diastolic free Ca i 2ϩ is comparable to that observed in response to 2 mM Ca o 2ϩ (Fig. 6); 3) ceramide enhances the Ca o 2ϩ response of CS; 4) recoveries of CS from PRP 30 -associated potentiation and from 2 mM Ca 2ϩ exposure in the presence of ceramide are slower than in its absence (Figs. 4B and 6C) ; and 5) ceramide induces an upward and leftward shift in the CS-tofluorescence ratio phase-plane trajectory, consistent with previous findings by others (34) , who showed that such shifts in the Ca i 2ϩ -cell length trajectory during the relaxation phase of contraction reflects an increase in myofilament Ca 2ϩ sensitivity in adult rat ventricular myocytes.
A study (9) using transfected Chinese hamster ovary cells expressing the bovine cardiac Na ϩ /Ca 2ϩ exchanger showed that 15 M C 2 -ceramide inhibited Na ϩ /Ca 2ϩ exchange activity. Our data showed that ceramide prolonged the rate of the decline phase of the caffeine-induced Ca 2ϩ transient, an indirect measure of sarcolemmal Na 2ϩ /Ca 2ϩ exchange due to the absence of SR uptake function (5), suggesting a decrease in Ca 2ϩ efflux via sarcolemmal Na ϩ /Ca 2ϩ exchange. However, the return of Ca i 2ϩ to the baseline level during diastole depends primarily on the SR Ca 2ϩ pump (contributing 92%) and the normal mode of Na ϩ /Ca 2ϩ exchange (7%) in rat ventricular myocytes (5) . Thus the reduction in the small fraction (i.e., Na ϩ /Ca 2ϩ exchange) in Ca i 2ϩ return during diastole could account for the observed little change in the diastolic Ca i 2ϩ level in the presence of ceramide.
The mechanism involved in ceramide-induced alterations in Ca 2ϩ sensitivity and SR Ca 2ϩ cycling and in the biophysical properties of the cell membrane remains unknown. The dissociation of its inotropic effects from its electrophysiological effect could result from its diversity of cell signaling mechanisms and alterations in the lipid microenvironment of ion channels (17) . For example, ceramide has been reported to activate protein kinases (including PKC and MAPK) as well as protein phosphatases (13, 16, 27, 30) . Activation of protein phosphatases could reduce I Ca,L , whereas activation of protein kinases could enhance contractile protein activities. Similarly, the target proteins involved in the ceramide-induced positive inotropic effect in ventricular myocytes also remain largely unknown and require further investigation.
In summary, the increase in ceramide resulting from stimulation of proinflammatory cytokines causes an increase in intracellular free Ca 2ϩ and contractility, probably due to increases in SR Ca 2ϩ release and uptake, and in the Ca 2ϩ sensitivity of contractile proteins, despite a reduction of I Ca,L . Ceramide-elicited effects can be beneficial (as a Ca 2ϩ -sensitizing and positive inotropic agent) or deleterious (as a potential arrhythmogenic agent). The cardiac effects of ceramide could play an important role in cytokine-related pathophysiological conditions such as ischemia-reperfusion, hypoxia, and sudden cardiac death.
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